Havn is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products from novel compounds.
With a research lab and offices located in the South Research Campus of The University of British Columbia and a team of scientists with extensive experience in chemistry and formulation development, the company is dedicated to helping people operate at peak mental performance and experience a considerable reduction in symptoms associated with mental illness.
Dr. Ivan Casselman
Chief Psychedelics Officer
Chief Research Officer